These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8744803)

  • 41. Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression.
    Kolár Z; Murray PG; Zapletalová J
    Neoplasma; 2002; 49(2):110-3. PubMed ID: 12088102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
    Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
    Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
    Ferrero-Poüs M; Hacène K; Bouchet C; Le Doussal V; Tubiana-Hulin M; Spyratos F
    Clin Cancer Res; 2000 Dec; 6(12):4745-54. PubMed ID: 11156229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].
    Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1181-5. PubMed ID: 1675844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
    Suo Z; Risberg B; Kalsson MG; Willman K; Tierens A; Skovlund E; Nesland JM
    J Pathol; 2002 Jan; 196(1):17-25. PubMed ID: 11748637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.
    Almasri NM; Al Hamad M
    Breast Cancer Res; 2005; 7(5):R598-604. PubMed ID: 16168103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
    Horiguchi J; Iino Y; Takei H; Morishita Y
    Jpn J Clin Oncol; 1995 Aug; 25(4):119-23. PubMed ID: 7666587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas.
    Skomedal H; Kristensen G; Holm R
    Gynecol Oncol; 1995 Dec; 59(3):379-83. PubMed ID: 8522259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical expression of epidermal growth factor receptor in breast cancer.
    Nozoe T; Mori E; Iguchi T; Egashira A; Adachi E; Matsukuma A; Ezaki T
    Breast Cancer; 2011 Jan; 18(1):37-41. PubMed ID: 20204554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
    Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
    J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Overexpression of c-erbB-2 gene product is associated with poor prognosis factors in breast carcinoma].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):349-53. PubMed ID: 14755939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early and more advanced unifocal and multifocal breast carcinomas and their molecular phenotypes.
    Tot T
    Clin Breast Cancer; 2011 Aug; 11(4):258-63. PubMed ID: 21729662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Correlation between lymph-node metastasis and combined expression of Hpa and C-erbB-2 of invasive ductal breast carcinoma].
    Zheng XD; Xiao CB; Mao DH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):52-4. PubMed ID: 18390199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?
    Burness ML; Grushko TA; Olopade OI
    Cancer J; 2010; 16(1):23-32. PubMed ID: 20164687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness.
    Betta PG; Robutti F; Spinoglio G; Bottero G
    Pathologica; 1989; 81(1074):425-31. PubMed ID: 2626279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.